What is Kastus?
Founded in 2014 and headquartered in Dublin, Ireland, Kastus® is at the forefront of combating antimicrobial resistance through its innovative surface solution. The company employs a novel photo-physical coating process that utilizes ambient air moisture and light to generate reactive oxygen species. This process effectively disrupts bacterial cell walls, eliminating pathogens without the risk of resistance development. The 'always on' antimicrobial power is sustained throughout the product's lifetime due to the unlimited fuel source, positioning Kastus as a key player in developing advanced antimicrobial technologies.
How much funding has Kastus raised?
Kastus has raised a total of $6.7M across 1 funding round:
Series A
$6.7M
Series A (2021): $6.7M with participation from Ascent Alpha
Key Investors in Kastus
Ascent Alpha
Ascent Alpha, based in Toronto, Canada, is a management consulting firm that has provided backing to Kastus. Their involvement suggests a strategic interest in companies with innovative technological solutions.
What's next for Kastus?
The recent major strategic investment signals a pivotal growth phase for Kastus, likely enabling the company to scale its operations, expand its market reach, and further develop its proprietary coating technology. This capital infusion is expected to accelerate the deployment of Kastus's solutions across various industries, reinforcing its mission to mitigate the global threat of antimicrobial resistance and establish its technology as a standard in surface protection.
See full Kastus company page
